What we are studying
The purpose of this study is to learn if the drug topiramate slows the progression of Cryptogenic Sensory Peripheral Neuropathy (CSPN) (also known as "idiopathic neuropathy"), and improves quality of life. Idiopathic neuropathy is nerve damage that interferes with the functioning of the peripheral nervous system and the cause of the nerve damage is unknown. As part of this study, we will use a number of assessments and questionnaires to determine if topiramate improves symptoms of CSPN.
Compensation will be discussed with each potential participant.